T. Yonemoto

发表

Asymptomatic Congenital Hyperinsulinism due to a Glucokinase-Activating Mutation, Treated as Adrenal Insufficiency for Twelve Years

Tatsuhide Inoue, K. Morishita, Chika Kyo, 2017, Case reports in endocrinology.

clinically-used ARBs: drug-target interaction analyses

M. Orita, Tomohiko Yamaguchi, H. Masuzaki, 2014 .

Low-dose glimepiride with sitagliptin improves glycemic control without dose-dependency in patients with type 2 diabetes inadequately controlled on high-dose glimepiride.

Tatsuhide Inoue, K. Morishita, T. Yonemoto, 2014, Endocrine journal.

Distinct Properties of Telmisartan on Agonistic Activities for Peroxisome Proliferator-Activated Receptor γ among Clinically Used Angiotensin II Receptor Blockers: Drug-Target Interaction Analyses

M. Orita, Tomohiko Yamaguchi, H. Masuzaki, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Novel germline variant of TMEM127 gene in a patient with familial pheochromocytoma

K. Takekoshi, K. Yoshimura, T. Usui, 2017, Endocrinology, diabetes & metabolism case reports.

Parameters of captopril challenge test can predict results of other confirmatory tests for primary aldosteronism and propose the next test to be done.

M. Kotani, T. Usui, Tatsuhide Inoue, 2020, Endocrine journal.

Maduropeptin, a complex of new macromolecular antitumor antibiotics.

H. Kawaguchi, S. Forenza, M. Konishi, 1991, The Journal of antibiotics.

Parthenogenetic mosaicism: generation via second polar body retention and unmasking of a likely causative PER2 variant for hypersomnia

T. Ogata, H. Saitsu, K. Aoto, 2021, Clinical epigenetics.

ARMC5 Alterations in Primary Macronodular Adrenal Hyperplasia (PMAH) and the Clinical State of Variant Carriers

N. Kanamoto, T. Katabami, I. Kurihara, 2019, Journal of the Endocrine Society.

An Asymptomatic Case With MEN1 Slipping Through Genetic Screening by SNV-dependent Allelic Dropout

H. Ariyasu, M. Kotani, T. Usui, 2022, Journal of the Endocrine Society.

Glucocorticoid reamplification within cells intensifies NFκB and MAPK signaling and reinforces inflammation in activated preadipocytes

T. Yonemoto, 2010 .

Distinct Properties of Telmisartan on Agonistic Activities for Peroxisome Proliferator-Activated Receptor γ among Clinically Used Angiotensin II Receptor Blockers: Drug-Target Interaction Analyses

M. Orita, Tomohiko Yamaguchi, H. Masuzaki, 2014, The Journal of Pharmacology and Experimental Therapeutics.